On the biochemical mode of action of levamisole: An update
- 31 December 1991
- journal article
- review article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 13 (1) , 3-9
- https://doi.org/10.1016/0192-0561(91)90019-4
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Effects of levamisole on primary cultures of adult rat hepatocytesBiochemical Pharmacology, 1986
- Isolation of a cDNA clone coding for a possible neural nicotinic acetylcholine receptor α-subunitNature, 1986
- The dosage regimen of levamisole in cancer: Is it related to efficacy and safety?International Journal of Immunopharmacology, 1983
- Inhibition of interferon or soluble immune response suppressor (SIRS) mediated suppression by levamisoleInternational Journal of Immunopharmacology, 1983
- Levamisole and Immunotherapy: Some Theoretic and Practical Considerations and Their Relevance to Human DiseaseOncology, 1981
- Protective effect of levamisole and its sulfhydryl metabolite OMPI against cell death induced by glutathione depletionInternational Journal of Immunopharmacology, 1979
- Protection of rat liver microsomes from NADPH-, ascorbate-, and X-irradiation-induced lipid peroxidation by levamisoleInternational Journal of Immunopharmacology, 1979
- Dl-2-oxo-3-(2-mercaptoethyl)-5-phenylimidazolidine. A sulfhydryl metabolite of levamisole that interacts with microtubulesChemico-Biological Interactions, 1978
- Adjuvant treatment with levamisole in cancer a review of experimental and clinical dataCancer Treatment Reviews, 1977
- Effects of levamisole and imidazole on lymphocyte proliferation and cyclic nucleotide levelsCellular Immunology, 1975